DB&C Advisors’s Johnson & Johnson JNJ Stock Holding History

DB&C Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$855K	Buy	3,366 +15	+0.4%	+$3.5K	0.93%	29
2026 Q1	$819K	Buy	3,351 +15	+0.4%	+$3.49K	1.06%	29
2025 Q4	$690K	Buy	+3,336	New	+$660K	0.87%	33

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

DB&C Advisors's JNJ Position: Q2 2026 in Review

DB&C Advisors increased its Johnson & Johnson (JNJ) stake by 0.45% in Q2 2026, buying an estimated $3.5K and bringing the position to 3,366 shares worth $855K. The position accounts for 0.93% of the portfolio, ranked #29.

DB&C Advisors first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,670 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

DB&C Advisors held 3,366 shares of Johnson & Johnson worth $855K as of Q2 2026.
DB&C Advisors bought 15 Johnson & Johnson shares in Q2 2026, an estimated $3.5K.
Johnson & Johnson made up 0.93% of DB&C Advisors's portfolio in Q2 2026, its #29 holding.
DB&C Advisors first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
4,670 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on DB&C Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.